FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Comments Extended on Unapproved Sunscreen

[ Price : $8.95]

Federal Register Advance notice of proposed rulemaking: FDA extends the comment period on certain dosage forms of OTC sunscreen dr...

FDA, Xavier University Plan Global Outsourcing Conference

[ Price : $8.95]

Federal Register Notice: FDA Cincinnati District and Xavier University will co-sponsor a public conference 10/3-5 on improving glo...

FDA Supports Transcept Response Approach

[ Price : $8.95]

Transcept Pharmaceuticals says it was to meet 9/14 with FDA officials to discuss a regulatory path forward for its Intermezzo as a...

Genentech NDA for Skin Cancer Drug

[ Price : $8.95]

Genentech files an NDA for vismodegib, indicated for treating people with advanced basal cell carcinoma when surgery is not an opt...

Harkonen Excluded from Federal Health Programs

[ Price : $8.95]

The HHS Inspector General says that former InterMune CEO Scott Harkonen has been excluded from federal healthcare programs for fiv...

FDA 'Close-out' on Teva Warning Letter

[ Price : $8.95]

FDA issues a close-out letter to Teva Pharmaceutical Industries indicating that the company has resolved GMP isuues outlined in a ...

Insider Trading Defendant Facing Porn Charge

[ Price : $8.95]

Prosecutors charge Andrew Liang, a defendant in an FDA insider trading case, with possessing child pornography.

Many People Dont Understand FDA Drug Approval: Study

[ Price : $8.95]

Researchers say simple explanations could help consumers better understand what FDA drug approval does and does not mean about eff...

Cinryze Phase 2 Study Starts

[ Price : $8.95]

ViroPharma and Halozyme say they are starting a Phase 2 Cinryze trial using Halozymes Enhanze subcutaneous drug administration tec...

Upmost or Utmost? FDA Seems Not to Know

[ Price : $8.95]

FDA Webview editor Jim Dickinson takes three top FDAers to task for not seeming to know the importance of spelling.